Moxifloxacin: safety profile

The latest, so-called respiratory, fluoroquinolones are a group of antimicrobial agents (AMA), most commonly prescribed for community-acquired lower respiratory tract infection (caLRTI), which is a relevant issue in routine clinical practice.

Dades bibliogràfiques
Autor principal:	A. I. Sinopalnikov
Format:	Article
Idioma:	Russian
Publicat:	Remedium Group LLC 2013-12-01
Col·lecció:	Медицинский совет
Matèries:	респираторные фторхинолоны инфекции нижних дыхательных путей моксифлоксацин безопасность respiratory fluoroquinolones lower respiratory tract infections moxifloxacin safety
Accés en línia:	https://www.med-sovet.pro/jour/article/view/1152

Ítems similars

Community-acquired pneumonia against a background of chronic heart failure: diagnosis and treatment
per: A. A. Bobylev, et al.
Publicat: (2014-12-01)

Moxifloxacin in the treatment of community-acquired pneumonia in adults: what's new?
per: A. I. Sinopalnikov
Publicat: (2014-12-01)

Rational therapy of patients with lower respiratory tract infections
per: V. A. Kazantsev
Publicat: (2013-12-01)

Cough in children as a symptom of respiratory tract infections: a new look at the problem of antibiotic therapy
per: O. A. Egorova
Publicat: (2014-12-01)

Местная иммуномодуляция при заболеваниях верхних дыхательных путей
Publicat: (2018-06-01)

Combined treatment of acute maxillary sinusitis
per: A. I. Kryukov, et al.
Publicat: (2015-12-01)

Levofloxacin: role and place in the treatment of infections of the lower respiratorytracts
per: A I Sinopalnikov, et al.
Publicat: (2004-11-01)

Study of the efficacy and safety of levofloxacin and amoxicillin clavulanate in patients with acute bacterial sinusitis
per: A. I. Kryukov, et al.
Publicat: (2014-12-01)

Role of acute respiratory infection in the development of ent disease
per: K. A. Nikitin, et al.
Publicat: (2013-12-01)

Fluoroquinolones in ambulatory surgical practice: whom, when, how?
per: A. V. Golub, et al.
Publicat: (2016-06-01)

ANTIBIOTIC THERAPY FOR ENT INFECTIONS
per: A. B. Turovsky, et al.
Publicat: (2014-07-01)

ANTIBIOTIC THERAPY FOR ENT INFECTIONS
per: A. B. Turovsky, et al.
Publicat: (2014-07-01)

Safety of Moxifloxacin following repeated intramuscular administration in Wistar rats
per: K.A. Sadariya, et al.
Publicat: (2010-01-01)

Some aspects of comprehensive etiotropic treatment of infectious and inflammatory diseases of ENT organs
per: V. M. Svistushkin, et al.
Publicat: (2013-12-01)

Expectorants in combination treatment of upper respiratory tract infections in children
per: N. L. Kunelskaya, et al.
Publicat: (2015-12-01)

A Case Report of Severe Corneal Toxicity following 0.5% Topical Moxifloxacin Use
per: A.P. Vignesh, et al.
Publicat: (2015-02-01)

Проблема «трудных дыхательных путей»: многоцентровые исследования Федерации анестезиологов и реаниматологов по анализу текущей клинической практики и обзору системы обучения в Российской Федерации
per: Александр Александрович Андреенко, et al.
Publicat: (2019-09-01)

Respiratory fluoroquinolones in outpatient clinical practice
per: R. S. Kozlov, et al.
Publicat: (2015-12-01)

Current aspects of pharmacotherapy and prevention of ARVI
per: A. I. Kurkina, et al.
Publicat: (2015-12-01)

The role of cathepsin S in the pathophysiology of bronchial asthma
per: A. Yu. Kraposhina, et al.
Publicat: (2022-10-01)

The effectiveness of moxifloxacin in the treatment of community-acquired pneumonia
per: Dmytro Dmytriiev, et al.
Publicat: (2021-11-01)

Moxifloxacin Induced Seizures -A Case Report.
per: Jiana Shi, et al.
Publicat: (2014-09-01)

РЕЗЕКЦИЯ И РЕКОНСТРУКЦИЯ КАРИНЫ ТРАХЕИ В ОНКОХИРУРГИИ: ТЕХНИЧЕСКИЕ АСПЕКТЫ И РЕЗУЛЬТАТЫ
Publicat: (2016-06-01)

Acute respiratory infections in ENT practice
per: S. Y. Kosyakov, et al.
Publicat: (2013-12-01)

Зетамакс ретард - новая эффективная и безопасная форма азитромицина для однократного приема
Publicat: (2018-06-01)

Mucolytic therapy in children
per: E. V. Boytsova
Publicat: (2013-12-01)

About permanent urinary tract infections among women of giving age in the conditions of the north
per: V N Plekhanov
Publicat: (2012-12-01)

The role of probiotic agents in the prevention of seasonal incidence of ARVI
per: N. L. Kunelskaya, et al.
Publicat: (2013-12-01)

ARVI prevention in patients with nonspecific lung diseases
per: YA Gornostaeva
Publicat: (2014-12-01)

Prevention of bacterial respiratory tract infections in children
per: I. M. Melnikova, et al.
Publicat: (2016-12-01)

Peculiarities of Etiology of Respiratory Virus Infections in Hospitalized Patients Depending on the Demographic, Socio-Economic Factors and Previous Vaccination
per: A. A. Sominina, et al.
Publicat: (2015-06-01)

Сравнительная оценка применения интубирующих надгортанных воздуховодов LMA Fastrach™ и ILTS-D® в условиях нормальных и симулированных трудных дыхательных путей — исследование на манекене
per: Александр Александрович Андреенко, et al.
Publicat: (2017-03-01)

Подострый кашель у детей дошкольного возраста: дифференциальная диагностика и дифференцированная терапия в условиях амбулаторной практики
per: S.A. Mokiya–Serbina, et al.
Publicat: (2021-05-01)

Postoperative Safety Outcomes in Patients Undergoing Routine Phacoemulsification Cataract Surgery with Intraoperative Intracameral Injection of Preservative-Free Moxifloxacin versus Levofloxacin
per: Franz Marie Cruz, et al.
Publicat: (2022-06-01)

Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA
per: Lisa Trieu, et al.
Publicat: (2015-03-01)

Prevention of respiratory infections in children
per: N. G. Kolosova
Publicat: (2014-12-01)

Влияние протокола антимикробной терапии на результаты лечения респираторных инфекций у пациентов ОРИТ многопрофильного стационара
per: М. Н. Замятин, et al.
Publicat: (2020-06-01)

Современные аспекты выбора антимикробных препаратов при неосложненных инфекциях мочевых путей
Publicat: (2015-06-01)

Neoslozhnennaya infektsiya mochevykh putey
per: T S Perepanova
Publicat: (2006-04-01)

Macrolides in the treatment of community-acquired infections of lower respiratory tract
per: A. V. Golub, et al.
Publicat: (2013-12-01)